immune system
N |
• normal lymphocyte composition, as assessed by flow cytometry
|
• impaired MHC class II expression in response to CpG DNA
|
• no observed CpG-DNA-induced Th1-like response in vivo
|
• impaired ability to produce IL6, IL12 and TNF-alpha in response to CpG DNA
(J:66049)
• production of IL6, IL12, and TNF-alpha in response to LPS, PGN, lipoprotein from Escherichia coli, zymosan, and heat-killed Staphylococcus aureus was comparable to wild-type controls
(J:66049)
• response to CpG is considerably decreased compared to wild-type
(J:117688)
|
• impaired production of IL12 in response to CpG DNA, but not LPS
• impaired expression of CD40, CD80, CD86, and MHC II in response to CpG DNA, but not LPS
|
• resistant to CpG-DNA-induced shock syndrome compared to wild-type mice
• unlike wild-type controls, no increase in serum IL6, IL12, or TNF-alpha in response to CpG-DNA in vivo
|
hematopoietic system
• impaired MHC class II expression in response to CpG DNA
|
• no observed CpG-DNA-induced Th1-like response in vivo
|
• impaired ability to produce IL6, IL12 and TNF-alpha in response to CpG DNA
(J:66049)
• production of IL6, IL12, and TNF-alpha in response to LPS, PGN, lipoprotein from Escherichia coli, zymosan, and heat-killed Staphylococcus aureus was comparable to wild-type controls
(J:66049)
• response to CpG is considerably decreased compared to wild-type
(J:117688)
|